|
FAM160B1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.758070E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.449300E-04 |
| Normal-vs-Stage2 |
1.720580E-01 |
| Normal-vs-Stage3 |
6.559700E-02 |
| Normal-vs-Stage4 |
1.918050E-01 |
| Stage1-vs-Stage2 |
6.411600E-01 |
| Stage1-vs-Stage3 |
2.878800E-01 |
| Stage1-vs-Stage4 |
6.869800E-02 |
| Stage2-vs-Stage3 |
8.582200E-01 |
| Stage2-vs-Stage4 |
5.741000E-01 |
| Stage3-vs-Stage4 |
5.594400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.503430E-03 |
| Normal-vs-AfricanAmerican |
2.775800E-01 |
| Normal-vs-Asian |
2.627800E-02 |
| Caucasian-vs-AfricanAmerican |
3.436000E-01 |
| Caucasian-vs-Asian |
4.823800E-01 |
| AfricanAmerican-vs-Asian |
2.254000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.601000E-03 |
| Normal-vs-Female |
1.162070E-03 |
| Male-vs-Female |
3.325800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.746300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.955780E-04 |
| Normal-vs-Age(61-80Yrs) |
4.810000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.346600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.499200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.179400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.248180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.502200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.890000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.358000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.642360E-02 |
| Normal-vs-Grade 2 |
9.68540000000351E-05 |
| Normal-vs-Grade 3 |
1.877650E-01 |
| Normal-vs-Grade 4 |
2.909600E-01 |
| Grade 1-vs-Grade 2 |
2.166200E-01 |
| Grade 1-vs-Grade 3 |
3.573600E-02 |
| Grade 1-vs-Grade 4 |
3.504500E-02 |
| Grade 2-vs-Grade 3 |
1.639200E-03 |
| Grade 2-vs-Grade 4 |
6.398700E-03 |
| Grade 3-vs-Grade 4 |
8.998600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.44309999999959E-05 |
| Normal-vs-ccB subtype |
1.634310E-02 |
| ccA subtype-vs-ccB subtype |
1.804810E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.360700E-03 |
| Normal-vs-N1 |
2.807000E-01 |
| N0-vs-N1 |
8.782400E-01 |
|
|
